You are here

Coronary Stents (Drug-eluting, Bare Metal, Bioresorbable) Markets, 2024: Bioresorbable Stents are Likely to Offer Tremendous Growth Opportunities for Vendors

DUBLIN, July 17, 2019 /PRNewswire/ -- The "Coronary Stents (Drug-eluting, Bare Metal, Bioresorbable) Markets, 2024" report has been added to's offering.

The global coronary stent market is likely to reach more than 11 billion by 2024, growing at a CAGR of around 7% during 2018-2024.

The market research report on the coronary stent market covers market sizing and forecast, market share, industry trends, growth drivers, and vendor analysis.

Key Market Insights

  • Offers market sizing and growth prospects of functional coronary stent market for the forecast period 2019-2024
  • Provides comprehensive insights on the latest industry trends, market forecast, and growth drivers in the coronary stent market
  • Includes a detailed analysis of market growth drivers, challenges, and investment opportunities
  • Delivers a complete overview of market segments and the regional outlook of coronary stent market
  • Offers an exhaustive summary of the vendor landscape, competitive analysis, and key market strategies to gain a competitive advantage in the coronary stent market

Market Drivers

The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.

The growing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the coronary stent market. Over the years, coronary stents have witnessed several technological enhancements, particularly design innovations. Stent manufacturers are focusing primarily on R&D activities and commercialization of innovative drug-eluting stent (DES) systems due to the high prevalence of coronary artery diseases.

New product approvals are contributing majorly toward the growth of the market and are likely to have a significant impact on the adoption of coronary stents in the coming years. Abbott, B. Braun Melsungen, Boston Scientific, Biosensors International GroupMedtronic, BIOTRONIK, Microport Scientific, and Terumo have launched a diverse range of drug-eluting stents in recent years, which are expected to augur well for the growth of the coronary stent market.

Coronary Stent Market: Segmentation


  • Drug-eluting stents
  • Bare metal stents
  • Bioresorbable stents

Bare metal stents are growing at a steady rate. High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth bare metal stents. Further, the demand for bare metal stents is likely to grow primarily from price-sensitive markets such as developing and low-income countries, where the uptake of PCI procedures has steadily increased over the past few years.

Bioresorbable stents are growing at a faster pace and are likely to witness rapid growth during the forecast period. With the availability of a few commercial and promising investigational devices, bioresorbable stents are likely to offer tremendous growth opportunities for vendors in coming years.


  • Permanent coronary stents
  • Fully degradable coronary stents

The permanent coronary stents segment is growing significantly and captured more than half of the market in 2018. Permanent heart stents are non-degradable devices made up from metal alloys such as stainless steel, cobalt chromium, and platinum chromium. They are gaining prominence in the market due to their safety and efficacy.

Fully degradable heart stents are growing at a stable rate. The rise in CVDs, especially vascular diseases, has become a major growth driver for innovative fully degradable types. Further, the heart stent manufacturers are focusing on R&D activities and commercialization of innovative products such as BRSs. Several emerging and major players are actively engaged in the development and commercialization of BRSs due to their huge market potential. For instance, Abbott is developing Absorb, second-generation BRS, and is actively conducting clinical trials to gain regulatory approvals.


  • Hospitals
  • Specialty cardiology centers
  • Ambulatory surgical centers

Hospitals are the largest end-users of coronary stents. The growing aging population, changing lifestyle patterns, and the increasing prevalence of CVDs are fueling market growth. Further, a significant number of patients prefer to undergo surgeries in hospitals due to better reimbursement policies. The availability of reimbursement in hospitals is a major driver for the high volume of PCI procedures in the healthcare sector.The demand for highly advanced and innovative PCI procedures like robot-assisted techniques are being performed to implant a diverse array of drug eluting, bare metal, and bioabsorbable stents.


North America captured half of the global coronary stent market in 2018. The presence of a large pool of patient population with CAD requiring coronary stents, a high acceptance of advanced and innovative heart stents, and high awareness toward stent-based PCI procedures have collectively supported North America's dominance in the market.

Germany, the UK, France, Italy, and Spain are the major revenue contributors in the coronary stent market in Europe. The presence of highly sophisticated healthcare infrastructure, high awareness regarding advantages of PCI procedures, and increased R&D investments on innovative coronary stents are major driver driving the Europe coronary stent market.

Key Vendor Analysis

The coronary stent market is highly dynamic due to the presence of several global, regional, and local players offering a broad range of stents. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and investments in start-up and emerging companies to expand their presence, enhance product portfolio, and improve expertise in the market.

Leading players are focusing on implementing strategies such as product approvals, expanded indication approvals, conducting clinical trials, marketing, and promotional activities, acquisitions, increase R&D investment, and strengthen their distribution networks to enhance their market share and presence in the coronary stent market.

Key Topics Covered

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the Study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Design
4.4.3 Market Segmentation by End-users
4.4.4 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Coronary Artery Disease (CAD): An Overview
7.1.1 Symptoms
7.1.3 Etiology
7.1.4 Complications
7.1.5 Diagnosis
7.1.6 Treatment
7.2 PCI: An Overview
7.2.1 Coronary Stents

8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increased Prevalence/Incidence of Coronary Artery Disease
8.1.2 High Demand for DESs with Low Strut Thickness
8.1.3 High Demand for Coronary Stents in Emerging Markets
8.1.4 Technological Advancements/Innovations in Stent Platforms
8.2 Market Growth Restraints
8.2.1 Stringent Regulations for Product Approvals
8.2.2 Availability of Alternative Treatment Methods for CAD
8.2.3 Complications Associated with Coronary Stenting Procedure
8.3 Market Opportunities & Trends
8.3.1 Emergence of Bioresorbable Vascular Scaffolds
8.3.2 High Growth Potential of Third-generation DESs
8.3.3 New Product Approvals/Launches

9 Global Coronary Stents Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry

10 By Product Type
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Drug-eluting Stents
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.3.3 Global Drug-eluting Stents Market by Product Type
10.3.4 Second-generation Drug-eluting Stents: Market Size & Forecast
10.3.5 Latest-generation Drug-eluting Stents: Market Size & Forecast
10.4 Bare Metal Stents
10.4.1 Market Overview
10.4.2 Market Size & Forecast
10.5 Bioresorbable Stents
10.5.1 Market Overview
10.5.2 Market Size & Forecast

11 By Design Type
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Permanent Coronary Stents
11.3.1 Market Size & Forecast
11.4 Fully Degradable Coronary Stents
11.4.1 Market Size & Forecast

12 By End-Users
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Hospitals
12.3.1 Market Size & Forecast
12.4 Specialty Cardiology Centers
12.4.1 Market Size & Forecast
12.5 ASCs
12.5.1 Market Size & Forecast

13 By Geography
13.1 Market Snapshot & Growth Engine
13.2 Overview

14 North America
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Key Countries
14.3.1 US: Market Size & Forecast
14.3.2 Canada: Market Size & Forecast

15 Europe
15.1 Market Overview
15.1.1 Market Size & Forecast
15.2 Key Countries
15.2.1 Germany: Market Size & Forecast
15.2.2 France: Market Size & Forecast
15.2.3 UK: Market Size & Forecast

16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Japan: Market Size & Forecast
16.3.2 China: Market Size & Forecast
16.3.3 India: Market Size & Forecast

17 Latin America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Brazil: Market Size & Forecast
17.3.2 Mexico: Market Size & Forecast

18 Middle-East and Africa
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Turkey: Market Size & Forecast
18.3.2 Saudi Arabia: Market Size & Forecast

19 Competitive Landscape
19.1 Competition Overview
19.2 Market Share Analysis

20. Key Company Profiles
20.1 Abbott
20.1.1 Business Overview
20.1.2 Abbott in Global Coronary Stents Market
20.1.3 Major Product Offerings
20.1.4 Key Strategies
20.1.5 Key Strengths
20.1.6 Key Opportunities
20.2 Boston Scientific
20.3 Medtronic
20.4 Biotronik
20.5 Terumo
20.6 B. Braun Melsungen
20.7 Biosensors International Group

21. Other Prominent Vendors
21.1 Arterial Remodeling Technologies
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.2 Alvimedica
21.3 Balton
21.5 Cardionovum
21.6 CeloNova BioSciences
21.7 Comed
21.8 Cordis
21.9 Elixir Medical
21.11 Eucatech
21.12 Eurocor Tech
21.14 InSitu Technologies
21.15 Innovative Health Technologies
21.16 Lepu Medical Technology (Beijing)
21.17 Medinol
21.18 Meril Life Sciences
21.19 Micell Technologies
21.20 MicroPort Scientific
21.21 Minvasys
21.23 Q3 Medical Devices
21.24 REVA Medical
21.25 Rontis
21.26 S3V Vascular Technologies
21.27 Sahajanand Medical Technologies
21.30 Svelte Medical
21.31 Translumina Therapeutics
21.33 Vascular Concepts
21.34 Wellinq

22. Report Summary
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 Product Type
22.3.2 Design Type
22.3.3 End-users
22.3.4 Geography

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets